Wan-Wan Lin Selected Research

9- (2- chlorobenzyl)- 9H- carbazole- 3- carbaldehyde

7/2007	The anti-inflammatory actions of LCY-2-CHO, a carbazole analogue, in vascular smooth muscle cells.
7/2005	Cell apoptosis induced by a synthetic carbazole compound LCY-2-CHO is mediated through activation of caspase and mitochondrial pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wan-Wan Lin Research Topics

Disease

15	Neoplasms (Cancer) 01/2023 - 02/2004
13	Inflammation (Inflammations) 01/2023 - 01/2003
7	Necrosis 03/2014 - 12/2002
5	Mitochondrial Diseases (Mitochondrial Disease) 03/2024 - 12/2004
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 11/2018
4	Hypoxia (Hypoxemia) 09/2014 - 10/2008
4	Colonic Neoplasms (Colon Cancer) 03/2012 - 05/2007
3	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2009
2	Macular Degeneration (Age-Related Maculopathy) 01/2023 - 05/2019
2	Blindness (Hysterical Blindness) 01/2023 - 10/2020
2	Type 2 Diabetes Mellitus (MODY) 09/2021 - 01/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2019 - 10/2005
2	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 07/2003
2	Disease Progression 06/2017 - 03/2014
2	Neoplasm Metastasis (Metastasis) 06/2017 - 01/2009
2	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2015 - 10/2013
2	Autoimmune Diseases (Autoimmune Disease) 02/2015 - 04/2011
2	Starvation 09/2014 - 05/2013
2	Atherosclerosis 06/2012 - 07/2007
2	Leukemia 03/2012 - 07/2005
2	Reperfusion Injury 10/2006 - 01/2003
2	Ischemia 10/2006 - 04/2002
1	Central Nervous System Diseases (CNS Diseases) 04/2024
1	Retinal Degeneration 01/2023
1	Ganglion Cysts (Ganglion) 01/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Macular Edema 01/2023
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2023
1	Gout 01/2021
1	Rupture 01/2021
1	Arthritis (Polyarthritis) 01/2021
1	Basal Cell Carcinoma (Rodent Ulcer) 05/2020
1	Erythema 05/2020
1	Neuroinflammatory Diseases 02/2019
1	Tuberculosis (Tuberculoses) 02/2019
1	Chronic Hepatitis B 01/2019
1	Carcinogenesis 01/2019
1	Hepatitis 01/2019
1	Liver Neoplasms (Liver Cancer) 01/2019
1	Anemia 04/2017
1	Acute Erythroblastic Leukemia (Erythroleukemia) 04/2017
1	Lupus Nephritis 01/2017

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 04/2024 - 04/2002
5	CaspasesIBA 10/2012 - 12/2004
4	Retinaldehyde (Retinal)IBA 01/2023 - 05/2019
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 10/2006
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2010 - 10/2006
3	LigandsIBA 01/2022 - 01/2010
3	InflammasomesIBA 01/2021 - 01/2013
3	Adenosine Triphosphate (ATP)IBA 02/2018 - 10/2012
3	Beclin-1IBA 09/2014 - 07/2010
3	AMP-Activated Protein KinasesIBA 05/2013 - 05/2007
2	sodium iodateIBA 01/2023 - 10/2020
2	Pyruvaldehyde (Methylglyoxal)IBA 01/2023 - 01/2016
2	Syk KinaseIBA 01/2023 - 02/2015
2	Retinal Pigments (Pigments, Visual)IBA 01/2023 - 09/2015
2	Metformin (Glucophage)FDA LinkGeneric 01/2023 - 10/2020
2	Epidermal Growth Factor (EGF)IBA 01/2022 - 11/2018
2	C-Type Lectins (C-Type Lectin)IBA 02/2019 - 01/2013
2	Immunologic Factors (Immunomodulators)IBA 06/2017 - 04/2011
2	Biomarkers (Surrogate Marker)IBA 06/2017 - 04/2011
2	Phosphotransferases (Kinase)IBA 09/2015 - 03/2012
2	CytokinesIBA 10/2013 - 05/2007
2	Glucose (Dextrose)FDA LinkGeneric 05/2013 - 06/2012
2	TNF-Related Apoptosis-Inducing LigandIBA 03/2012 - 05/2007
2	Death Domain ReceptorsIBA 03/2012 - 05/2007
2	AntioxidantsIBA 02/2011 - 07/2010
2	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2010 - 01/2009
2	9- (2- chlorobenzyl)- 9H- carbazole- 3- carbaldehydeIBA 07/2007 - 07/2005
2	CholesterolIBA 07/2003 - 01/2003
2	Caspase 3 (Caspase-3)IBA 01/2003 - 04/2002
1	NucleotidesIBA 04/2024
1	Leucine (L-Leucine)FDA Link 04/2024
1	Apoptosis Inducing FactorIBA 03/2024
1	MethyltransferasesIBA 01/2023
1	Advanced Glycation End ProductsIBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	Uric Acid (Urate)IBA 01/2021
1	CathepsinsIBA 01/2021
1	Gefitinib (Iressa)FDA Link 01/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	ChemokinesIBA 01/2021
1	Cathepsin BIBA 01/2021
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 10/2020
1	Galectin 3 (LGALS3)IBA 05/2020
1	olaparibIBA 02/2020
1	Subunit VaccinesIBA 02/2019
1	Cord FactorsIBA 02/2019
1	Neuroprotective AgentsIBA 02/2019
1	BCG Vaccine FDA Link 02/2019
1	Insulin (Novolin)FDA Link 01/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019
1	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2018
1	Adenosine (Adenocard)FDA LinkGeneric 02/2018
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2017
1	AutoantibodiesIBA 01/2017
1	ResveratrolIBA 01/2017
1	Transforming Growth Factors (Transforming Growth Factor)IBA 09/2015

Therapy/Procedure

7	Therapeutics 01/2023 - 02/2004